Abbvie Inc
Abbvie Inc (ABBV) Expected Move
ABBV expected move through Nov 20, 2026 is 2.9%, with 4 days to expiration. The implied range is $286.42 to $303.64, based on the previous trading day's options prices.
Read more
Tracking the ABBV expected move helps you see how far Abbvie Inc's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. Abbvie Inc's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the ABBV expected move for this week's options, in real time.
The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For ABBV, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The ABBV expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks Abbvie Inc is unlikely to go.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.
Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the ABBV expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The Abbvie Inc expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about ABBV.
ABBV Price
Drag chart to pan. Drag axes to zoom.
| Expiration | DTE | Expected move (USD) | Expected move (%) | Upper price | Lower price |
|---|---|---|---|---|---|
| Nov 20, 2026 | 4 | $8.61 | 2.9% | $303.64 | $286.42 |
| Nov 27, 2026 | 11 | $11.00 | 3.7% | $306.03 | $284.03 |
| Dec 4, 2026 | 18 | $13.63 | 4.6% | $308.66 | $281.41 |
| Dec 11, 2026 | 25 | $16.84 | 5.7% | $311.87 | $278.19 |
As of Nov 13, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →